Premium
Amlodipine‐induced immune thrombocytopenia
Author(s) -
Garbe E.,
Meyer O.,
Andersohn F.,
Aslan T.,
Kiesewetter H.,
Salama A.
Publication year - 2004
Publication title -
vox sanguinis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.68
H-Index - 83
eISSN - 1423-0410
pISSN - 0042-9007
DOI - 10.1111/j.0042-9007.2004.00376.x
Subject(s) - amlodipine , medicine , discontinuation , thrombocytopenic purpura , immune thrombocytopenia , prednisolone , platelet , antibody , purpura (gastropod) , drug , immunology , immune system , gastroenterology , pharmacology , blood pressure , ecology , biology
Background and Objectives Drug‐induced thrombocytopenia is a serious, but rare, side‐effect of treatment with a number of drugs. In this report, we investigate the suspicion that amlodipine, a calcium‐channel blocker, was responsible for immune thrombocytopenia in a 79‐year‐old patient. Patient and Methods Our patient experienced two attacks of thrombocytopenic purpura after 10 years of treatment with amlodipine. Antibodies to platelets were tested by standard methods. Results Initially, the platelet count increased owing to treatment with prednisolone and intravenous immunoglobulin G, but decreased shortly after discontinuation of this treatment. The patient's serum was found to contain amlodipine‐dependent antibodies to platelets, and he recovered after stopping the drug. Conclusions Amlodipine can induce immune thrombocytopenia, which may strongly resemble autoimmune thrombocytopenia.